Drugs / RP 01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00439621 | Feb 2007 → Mar 2008 | allergic disease | Resistentia Pharmaceuticals AB | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RP 01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00439621 ↗ |
| Action | Inhibit | “able to block any allergen-triggered inflammatory reaction” NCT00439621 ↗ |